Patent application number | Description | Published |
20080243545 | SYSTEM AND METHOD OF AGGREGATING AND DISSEMINATING IN-CASE-OF-EMERGENCY MEDICAL AND PERSONAL INFORMATION - A system for aggregating and disseminating in-case-of-emergency (ICE) medical information to medical units. The system includes an ICE medical record server that stores medical records of respective subscribers, and automatically receive updates from health service entities visited by subscribers. When contacted by emergency dispatchers or first responders, the server sends subscribers medical information to first responders, emergency management agencies directly, via a dispatcher, or via a computer aided dispatch (CAD) system. The medical information may be arranged, emphasized, and/or filtered in a manner relevant to the on-going emergency. A communication device may wirelessly receive the medical information and pre-populate a pre-hospital care form with the information, which may be further orally annotated by the first responder. The completed PCR may then be sent to a PCR server for subsequent access by medical units that subsequently treat the subscriber. The medical server may further assist a public health agency to disseminate emergency information to selected subscribers, responders, and public health alerting systems. An ICE personal server for storing important personal documents is also disclosed. A PCR server is also disclosed that can disseminate aggregate PCR information in near real-time to an emergency management agency (EMA) system for developing incident response plans during a wide area emergency. | 10-02-2008 |
20100063841 | SYSTEM AND METHOD OF NOTIFYING DESIGNATED ENTITIES OF ACCESS TO PERSONAL MEDICAL RECORDS - A medical information server and corresponding methods are disclosed for processing of personal medical information, providing some or all of the medical information to authorized requesting entities, and providing notifications of access to personal medical records to designated entities. The server may receive a request for personal medical record information from a communications device of a requesting entity; authenticate and authorize the request; send the requested information to the authorized requesting entity; and send notification of the access to one or more designated entities. The server may further update an access history pertaining to the personal medical record to note the access. The server may further receive a request for the access history of a personal medical record, and send the requested access history information to the authorized requesting entity. Additionally, the server may send notification of the access to the history to one or more designated entities. | 03-11-2010 |
Patent application number | Description | Published |
20090304688 | Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators - The present invention relates to methods and compositions for increasing the efficiency of therapeutic antibodies. More particularly, the invention relates to the use of a therapeutic antibody in combination with a γδ T cell activating compound or activated γδ T cells. thereby allowing a potentiation of γδ T cell cytotoxicity in mammalian subjects in order to enhance the efficiency of the treatment in human subjects, particularly through an increase of the depletion of targeted cells. | 12-10-2009 |
20100189681 | Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of Cancer - The present invention therefore provides novel approaches and strategies for efficient regulation of γδ T cells in vivo, in a subject, particularly a human subject or a non-human primate. The present invention now discloses particular compositions and methods that can be used to induce the proliferation of γδ T cells in vivo, in a subject. These compositions and methods employ the conjoint treatment of an individual with a γδ T cell activating compound and IL-2 and are particularly suited for immunotherapy in a subject, particularly in a subject having a cancer or an infectious disease. | 07-29-2010 |
20100254940 | Compositions and Methods for Regulating an Immune Response in a Subject - The present invention relates to compositions an methods for regulating an immune response in a subject, particularly to treat a subject with a tumor, notably a solid tumor, or an infectious disease. Disclosed are methods of regulating the innate immunity in a subject, such as by regulating the activity of γδ T cells in a subject. Disclosed are combinations of particular agents, such as a cytokine and a γδ T cell activator, particular administration regimens and dosages can produce a remarkable expansion of γδ T cells in vivo and a remarkable increase in a subject's immune defense. The invention can be used for therapeutic purposes, to produce, regulate or facilitate an immune response in a subject. | 10-07-2010 |
20150232556 | KIR3DL2 BINDING AGENTS - The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same. | 08-20-2015 |
20150291692 | KIR3DL2 BINDING AGENTS - The present invention relates to a method of predicting or monitoring the sensitivity of a subject having a tumor to a chemotherapy, to a method of selecting an appropriate chemotherapeutic treatment of cancer, to a method of screening or identifying a compound suitable for improving the treatment of a cancer, and to corresponding kits. The method of predicting or monitoring the sensitivity of a subject having a tumor to a chemotherapy typically comprises a step a) of determining, in a biological sample from said subject, the presence, absence or expression level of at least one of a soluble B7H6 (sB7H6 or sB7-H6) and a soluble MIC (sMIC) and when the expression level is determined a step b) of comparing said expression level to a reference expression level, thereby assessing or monitoring whether the subject having a tumor is responsive or resistant to the chemotherapy. | 10-15-2015 |
20150376274 | TREATMENT OF PERIPHERAL T CELL LYMPHOMA - The present disclosure relates to methods for the treatment, prevention and diagnostic of peripheral T cell lymphoma using compounds that specifically bind NKp46. Included in particular are compounds that bind NKp46 and deplete tumor cells that express at their surface NKp46, and pharmaceutical compositions comprising the same. The disclosure also relates to use of antibodies that specifically bind NKp46 in diagnostic and theranostic assays in the detection and treatment of peripheral T cell lymphoma. | 12-31-2015 |
20160002345 | A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA - The present disclosure relates to methods for the treatment, prevention and diagnostic of peripheral T cell lymphoma using compounds that specifically bind KIR3DL2. The disclosure also relates to use of antibodies that specifically bind KIR3DL2 in diagnostic and theranostic assays in the detection and treatment of peripheral T cell lymphoma. | 01-07-2016 |
Patent application number | Description | Published |
20100185482 | METHOD FOR CONTROLLING A SUPPLY CHAIN - The present document describes a method, a processor platform and a processor readable medium for controlling a supply chain for moving goods by agents according to orders. The method is for controlling globally and/or individually, and for optimizing based on live events, in real-time, in a single or multi company environment, simultaneously many well known business activities such as customer relationship management (CRM), pickup calls phone services, scheduling, monitoring of picking up and delivery of parcels and operations status, of transfer, of terminal, of interleaving and of deliveries, human resource management, pricing, maintenance, engine monitoring, device monitoring and invoicing, offering thus integrated solutions to each segment of the market of goods transportation in a single system. The method comprises: updating a knowledge base populated with statuses of the goods; statuses of the agents; rules for establishing expected behaviors of the goods and of the agents; and the orders. The method further comprises: determining, based on the knowledge base, instructions to be executed by the agents for moving the goods to achieve the orders, each one of the instructions having an expected completion duration; sending the instructions to the agents; receiving the instructions for execution by the agents; upon completion an instruction by an agent or when an event affects an instruction executed by an agent, the same agent sending the status of a good or its own status to the knowledge base; and returning to the updating a knowledge base, wherein each elapsed time between each agent sending the status of a good or its own status to the knowledge base and the same agent receiving an instruction is smaller that the expected completion duration of the same instruction. | 07-22-2010 |
Patent application number | Description | Published |
20100071460 | Signal quality of field effect transistor-based humidity sensors or gas sensors - Humidity or a gas concentration or a solvent concentration in at least one gas is detected by a field effect transistor-based gas sensor whose sensor signal is generated by the change in the work function on a sensitive film. Detection is to be provided in a simple, effective and inexpensive manner. An additional change in potential is impressed at a gate of the field effect transistor and a variable of the resulting change in the sensor signal relative to the additional change in potential is evaluated. For example, each variable, which is e.g. a ratio, can be assigned a relative humidity, a gas concentration, or a solvent concentration. Sensitive films having at least one polymer are particularly advantageous. | 03-25-2010 |
20100106039 | Unknown - Example embodiments relate to a device for measuring nitrogen monoxide in exhaled air by a gas sensor unit with at least one gas sensor. A device and/or method for oxidation of nitrogen monoxide to nitrogen dioxide may be included. The device and/or method for oxidation of nitrogen monoxide to nitrogen dioxide includes a non-consuming catalyst for catalyzing the oxidation of nitrogen monoxide to nitrogen dioxide. | 04-29-2010 |
20120282142 | GAS SENSOR - Volatile organic compounds or oxidizing gases are detected when the work function of a metal-organic framework is measured to produce a sensor signal. | 11-08-2012 |
20140109649 | DEVICE AND METHOD FOR DETERMINING CARBON DIOXIDE CONTENT OF AIR - A gas sensor, for example for use in air conditioning systems, has a gas-sensitive layer that includes a material that is sensitive to carbon dioxide. The material has a cross-sensitivity to air humidity. This is compensated for by measurement at two different temperatures. The measured gas values are calculated together, with the assumption that the sensitivity of the gas sensor to carbon dioxide exhibits a different curve with the temperature of the gas sensor than the sensitivity to water. | 04-24-2014 |